英文摘要 |
Arrhythmic syncope refers to brady- or tachyarrhythmia-induced syncope. Bradyarrhythmia related syncope includes sick sinus syndrome and atrioventricular block. Pacemaker implantation is beneficial to syncope improvement if there is electrocardiographic evidence of sinus arrest, sinoatrial block, or prolonged sinus pause after supraventricular tachycardia. However, recurrent syncope may develop even with pacemaker implantation if there is no electrocardiographic abnormality. In terms of atrioventricular block, pacemaker is applied to the treatment of syncope related atrioventricular block. Many studies indicate that pacing is highly effective in preventing syncope recurrences when atrioventricular block is documented. Tachyarrhythmia related syncope includes supraventricular tachycardia and paroxysmal ventricular tachycardia. First line therapy for tachyarrhythmia related syncope is catheter ablation. If tachyarrhythmia is accompanied by structural heart disease or left ventricular dysfunction, implantable cardioverter defibrillator should be considered for preventing sudden cardiac death. Here, we summarize 2018 European society of cardiology guidelines for the diagnosis and management of syncope, and will focus on the diagnosis and management of arrhythmic syncope. |